BA Research Update — July 7, 2026
Updated Thesis
The Boeing Company operates in the Industrials sector within the Aerospace & Defense industry, manufacturing commercial jetliners, defense, space, and security systems. Despite a challenging operating margin of -5.9% and a negative free cash flow per share of -2.46, Boeing shows strong recent earnings growth of 89.2% and revenue growth of 14.0% in the most recent quarter, signaling a potential recovery phase. The stock trades at a high trailing and forward P/E of 96.92, reflecting market skepticism or growth expectations, while the EV/EBITDA multiple of 30.4 suggests a premium valuation.
The investment grade as of this refresh is C — average business quality. Medium-tier business, expensive valuation
Key Metrics at a Glance
- Revenue growth: +14.0% year over year
- Net margin: 2.5%
- Forward P/E: 96.9x
- Fair value upside: +45.0% to our estimate of $340
Current price: $234.54
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. The Boeing Company remains in our covered universe with a average-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full BA research →](/stocks/BA)